Insights from 2023 ESMO Annual Meeting


 

ESMO 2023 Insights: "Safety & Efficacy of Low-Dose Ipi + Pembro in Checkpoint Inhibitor-Naïve Patients With Melanoma Brain Metastases"

54 views
November 6, 2023
Comments 0
Login to view comments. Click here to Login